Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling

You-Take Oh1, Shi-Yong Sun1

  • 1Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA 30322, USA.

Biomolecules
|April 3, 2021
PubMed

Insights

The TRAIL/death receptor pathway regulates cancer metastasis through complex mechanisms. This review explores its dual role in cancer cell invasion and spread.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Signaling

Background:

  • Death ligands, like tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and their receptors initiate apoptosis.
  • TRAIL/death receptor signaling also influences non-apoptotic functions, including inflammation and cancer metastasis.
  • The role of TRAIL/death receptor signaling in cancer invasion and metastasis is complex, with reported positive and negative effects.

Purpose of the Study:

  • To review the current understanding of TRAIL/death receptor signaling in regulating cancer cell invasion and metastasis.
  • To elucidate the complex molecular mechanisms underlying the involvement of this pathway in cancer progression.

Main Methods:

  • Literature review of studies on TRAIL/death receptor signaling.
  • Analysis of research on the pathway's role in cancer cell invasion and metastasis.
  • Synthesis of current knowledge on molecular mechanisms.

Main Results:

  • The TRAIL/death receptor pathway has a multifaceted role in cancer metastasis.
  • Both pro-metastatic and anti-metastatic functions have been attributed to this signaling pathway.
  • Complex molecular mechanisms mediate these opposing effects.

Conclusions:

  • The TRAIL/death receptor pathway is a critical regulator of cancer cell invasion and metastasis.
  • Further research is needed to fully understand and potentially target these complex signaling networks for therapeutic benefit.
  • Understanding the dual roles of TRAIL signaling is crucial for developing effective cancer treatments.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.8K